Vuja De Sciences
Hoboken, NJ
Vuja De Sciences develops cancer metastasis treatments that prevent cancer progression and recurrence. They utilize leading laboratory technologies for metastatic preclinical endpoints in combination with Comparative Oncology to de-risk and inform product development and maximize the likelihood of successful human oncology clinical trials. It approaches used for cancer maintenance therapy and adjuvant therapy target the same mechanisms applied to either primary tumors or macro-metastatic tumors.
vujade-life.comEmploybl Premium
Get the inside track on Vuja De Sciences
Premium profiles, AI research on tech stack and hiring, 61,000+ ATS job listings, saved searches, and an AI chat that knows the SF startup scene.
- AI chat about Vuja De Sciences's culture, stack, and interview process
- Save jobs and get alerts on new openings
- Full premium profiles across our company index
- 7-day free trial, then $25/mo. Cancel anytime.
Company Details
Founded
- 2017
Employees
- Between 5 - 20 employees
Raised
- $2,837,400
Headquarters Location
- Hoboken, NJ
Public
- No
Acquired
- No
CEO
David Warshawsky
Founders
- David WarshawskyRick LampeRaphael NirRobert E. Hurst
Company Collections
These are collections Vuja De Sciences is a part of. Click on the collection name to view similar companies.
Vuja De Sciences' Industries
Vuja De Sciences Headquarters Location
Total Amount Raised: $2,837,400
Vuja De Sciences Funding Rounds
Series Unknown
$1,070,000
Series Unknown
$1,070,000
Series Unknown
$391,060
Series Unknown
$391,060
Series Unknown
$875,000
Series Unknown
$875,000
Debt Financing
$501,340
Debt Financing
$501,340
Vuja De Sciences Reviews
0 out of 5 stars
Based on 0 reviews
Review data
Share your thoughts
Worked here? Share your experience. Help others decide if this company is right for them. Write a review on Vuja De Sciences.